A critical advance in cancer investigation is arising with the use of mini-antibodies to reactivate mutated p53. This crucial tumor protector protein is frequently inactivated in several kinds of cancer, leading https://apollobookmarks.com/story21880080/vhh-fragments-reactivate-p53-the-potential-approach-for-tumor-management